abstract |
The invention provides the use of a pharmaceutical composition containing chlorogenic acid in preparing a medicine for treating early Alzheimer's disease, and belongs to the field of biomedicine. In the pharmaceutical composition of the present invention, chlorogenic acid is used as the main active ingredient, and 3-coumaroylquinic acid is used as an auxiliary ingredient, and the latter can effectively enhance the curative effect of chlorogenic acid in treating early Alzheimer's disease. The research and development of the pharmaceutical composition of the present invention is of great significance for intervening from the early stage of Alzheimer's disease, delaying the progression of Alzheimer's disease, and improving the quality of life of patients. |